Clinical Predictors of Response to Treatment with Tofacitinib (Janus Kinase Inhibitor) in Patients with Ankylosing Spondylitis. (2025). Indus Journal of Bioscience Research, 3(4), 175-181. https://doi.org/10.70749/ijbr.v3i4.1020